{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:03:48Z","timestamp":1778684628977,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","award":["2014-0467"],"award-info":[{"award-number":["2014-0467"]}],"id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jgar.2021.11.010","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T12:04:54Z","timestamp":1638965094000},"page":"520-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Observational cross-sectional case study of toxicities of antifungal drugs"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrea M.","family":"Burden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Hausammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Kupferschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-7597","authenticated-orcid":false,"given":"Stefan","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.jgar.2021.11.010_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/03007995.2012.761135","article-title":"Optimizing antifungal choice and administration","volume":"29","author":"Andes","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jgar.2021.11.010_bib0002","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2021.11.010_bib0003","doi-asserted-by":"crossref","first-page":"i26","DOI":"10.1093\/jac\/dkx446","article-title":"Tolerability profile of the current antifungal armoury","volume":"73","author":"Mourad","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.010_bib0004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4254\/wjh.v6.i8.601","article-title":"Assessing liver injury associated with antimycotics: concise literature review and clues from data mining of the FAERS database","volume":"6","author":"Raschi","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Labor\u00edn","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/kfx029","article-title":"Hepatocellular toxicity of imidazole and triazole antimycotic agents","volume":"157","author":"Haegler","year":"2017","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jgar.2021.11.010_bib0007","first-page":"170","article-title":"Hepatotoxicity of antifungal agents","volume":"6","author":"Song","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jgar.2021.11.010_bib0008","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1592\/phco.28.5.614","article-title":"Current options in antifungal pharmacotherapy","volume":"28","author":"Mohr","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2021.11.010_bib0009","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jgar.2021.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jcph.400","article-title":"Liver injury associated with ketoconazole: review of the published evidence","volume":"54","author":"Greenblatt","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0011","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jac\/dkp219","article-title":"Toxicokinetics of voriconazole during massive intentional poisoning","volume":"64","author":"Roz\u00e9","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.010_bib0012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2133\/dmpk.DMPK-13-NT-007","article-title":"A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms","volume":"28","author":"Lemaitre","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jgar.2021.11.010_bib0013","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.transci.2018.09.015","article-title":"The utility of therapeutic plasma exchange for amphotericin B overdose","volume":"57","author":"Monroig-Bosque","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jgar.2021.11.010_bib0014","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/fcp.12422","article-title":"Inflammation is a potential risk factor of voriconazole overdose in hematological patients","volume":"33","author":"Gautier-Veyret","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.12178","article-title":"Risk of oral antifungal agent-induced liver injury in Taiwanese","volume":"77","author":"Kao","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2125.1999.00095.x","article-title":"A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs","volume":"48","author":"Garc\u00eda Rodr\u00edguez","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0017","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/15563659809028940","article-title":"Poisoning severity score. Grading of acute poisoning","volume":"36","author":"Persson","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13693780701730469","article-title":"Renal impairment and amphotericin B formulations in patients with invasive fungal infections","volume":"46","author":"Saliba","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8629891","article-title":"Renal recovery following liposomal amphotericin B-induced nephrotoxicity","volume":"2019","author":"Personett","year":"2019","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0020","doi-asserted-by":"crossref","first-page":"e02651","DOI":"10.1128\/AAC.02651-16","article-title":"Retrospective cohort analysis of liposomal amphotericin B nephrotoxicity in patients with hematological malignancies","volume":"61","author":"Stanzani","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.11.010_bib0021","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.11.010_bib0022","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/AAC.00525-15","article-title":"Incidence, predictors, and impact on hospital mortality of amphotericin B nephrotoxicity defined using newer acute kidney injury diagnostic criteria","volume":"59","author":"Rocha","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.11.010_bib0023","unstructured":"Swissmedic. Swissmedic Vigilance\u2013News Edition 21\u2013November 2018. Swissmedic; 2019. https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/humanarzneimittel\/marktueberwachung\/pharmacovigilance\/vigilance-news\/vigilance-news-21.html [accessed 17 July 2019]."},{"key":"10.1016\/j.jgar.2021.11.010_bib0024","first-page":"24","article-title":"ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous","volume":"22","author":"Koczmara","year":"2011","journal-title":"Dynamics"},{"key":"10.1016\/j.jgar.2021.11.010_bib0025","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1111\/j.1572-0241.1999.01623.x","article-title":"Severe cholestasis related to itraconazole for the treatment of onychomycosis","volume":"94","author":"Talwalkar","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgar.2021.11.010_bib0026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.amjmed.2015.10.029","article-title":"Oral azole antifungal medications and risk of acute liver injury, overall and by chronic liver disease status","volume":"129","author":"Lo Re","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jgar.2021.11.010_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.11.010_bib0028","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650701233370","article-title":"Understanding the limitations of retrospective analyses of poison center data","volume":"45","author":"Hoffman","year":"2007","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:59:32Z","timestamp":1761991172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521002629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"alternative-id":["S2213716521002629"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.11.010","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational cross-sectional case study of toxicities of antifungal drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}